Senate BillPassed first houseHealth and Safety
SB 6: Controlled substances: xylazine.
What SB 6 does, verified December 7, 2025
This bill aims to add xylazine to the list of Schedule III controlled substances in California. It would restrict the prescription, sale, and use of xylazine, except for certain exceptions such as its use in animal drugs. The bill would also exclude testing equipment designed to analyze xylazine from the prohibitions on paraphernalia. Additionally, it would create a new crime and impose a state-mandated local program. The bill does not require reimbursement for certain costs.
Bill journey
✓IntroducedComplete
✓In CommitteeComplete
✓First Chamber FloorComplete
4Second ChamberCurrent
5GovernorPending
6ChapteredPending
Last action: August 29 hearing: Held in committee and under submission. (2025-08-29)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $15/moUnlockRecent actions19 total · showing 5
| Aug. 29, 2025 | August 29 hearing: Held in committee and under submission. |
| Jul. 16, 2025 | July 16 set for first hearing. Placed on APPR. suspense file. |
| Jul. 16, 2025 | July 16 set for first hearing. Placed on suspense file. |
| Jul. 02, 2025 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (July 1). Re-referred to Com. on APPR. |
| Jun. 09, 2025 | Referred to Com. on PUB. S. |